← Leaderboards
Salum Juma Lidenge
Muhimbili University/ Allied Hlth Scis
$740,517
Attributed
$740,517
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $192.1K · FY2019–23$200K$150K$100K$50K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$740,517 · 1
By mechanism
K43$740,517 · 1
Top collaborators
No co-investigators on record.
Most similar at Muhimbili University/ Allied Hlth Scis
Same institution · by research overlap
- Elia John Mmbaga$804,383
Others in their field
Other Emerging Leaders on “Co-Infection”
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$72,037,072
- Thomas Denny · Duke University$23,095,705
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,639,518
- Michael Dignam · National Institute Of Allergy And Infectious Diseases$15,395,607
- Kevin Urdahl · Seattle Children'S Hospital$14,358,263
- Sara Albert · Leidos Biomedical Research, Inc.$9,235,930
Research focus
Co-InfectionRecruitBiological MarkersHiv-1Africa South Of The SaharaTanzaniaPlasmaImmunologic MarkersKaposi SarcomaCaringAntiretroviral TherapyReportingChronicResponseTumorMalignant NeoplasmsOceansHuman Herpesvirus 8Acquired Immunodeficiency SyndromeEarly DiagnosisImmune ResponseMortalityPrevalenceViral
Grant awards (8)
"Plasma and cellular immune biomarkers of Kaposi's sarcoma in HIV-1 suppressed patients"$99,955
K43 · FY2023 · TW · contact PI
"Plasma and cellular immune biomarkers of Kaposi's sarcoma in HIV-1 suppressed patients"$92,175
K43 · FY2023 · TW · contact PI
"Plasma and cellular immune biomarkers of Kaposi's sarcoma in HIV-1 suppressed patients"$99,316
K43 · FY2022 · TW · contact PI
"Plasma and cellular immune biomarkers of Kaposi's sarcoma in HIV-1 suppressed patients"$92,175
K43 · FY2022 · TW · contact PI
"Plasma and cellular immune biomarkers of Kaposi's sarcoma in HIV-1 suppressed patients"$92,175
K43 · FY2021 · TW · contact PI
"Plasma and cellular immune biomarkers of Kaposi's sarcoma in HIV-1 suppressed patients"$80,371
K43 · FY2021 · TW · contact PI
"Plasma and cellular immune biomarkers of Kaposi's sarcoma in HIV-1 suppressed patients"$92,175
K43 · FY2020 · TW · contact PI
"Plasma and cellular immune biomarkers of Kaposi's sarcoma in HIV-1 suppressed patients"$92,175
K43 · FY2019 · TW · contact PI